Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Showing 73–80 of 80 articles · Keyword: DNA Clear keyword

Gene Therapy2005ReviewNon-viral Gene Delivery

73. Nuclear entry of nonviral vectors

Dean Da, Strong Dd, Zimmer We.

Nonviral gene delivery is limited by multiple extracellular and intracellular barriers, but the nuclear envelope remains a major unresolved barrier, especially in nondividing cells. Plasmids must enter the nucleus to be transcribed, yet the mechanisms of plasmid nuclear import are much less understood than protein…

Read the article
Expert Opinion on Drug Delivery2005ReviewNon-viral Gene Delivery

74. Cationic liposomes for gene delivery

Sérgio Simões, Ana Da Silva Filipe, Henrique Faneca, Miguel Mano, Nuno Penacho, Nejat Düzgüneş, Maria C. Pedroso De Lima

Cationic liposome–DNA complexes (lipoplexes) are a potentially viable non-viral alternative to viral vectors for therapeutic gene delivery, but they suffer from limited delivery/gene expression efficiency, toxicity at higher concentrations, adverse interactions with serum and cell surfaces, and poor tissue access…

Read the article
Nature Reviews Drug Discovery2005ReviewNon-viral Gene Delivery

75. DESIGN AND DEVELOPMENT OF POLYMERS FOR GENE DELIVERY

Pack, D. W.; Hoffman, A. S.; Pun, S.; Stayton, P. S

The lack of safe and efficient gene-delivery methods remains a limiting obstacle to human gene therapy. Synthetic vectors are safer than recombinant viruses but generally lack sufficient efficacy, so polymers must be rationally designed to overcome extracellular and intracellular delivery barriers. PEI: Only 15–20%…

Read the article
2001ReviewNon-viral Gene Delivery

76. Design and gene delivery activity of modified polyethylenimines

Kircheis, R.; Wightman, L.; Wagner, E

PEI is one of the most effective non-viral gene delivery polymers, but its efficacy, toxicity, and in vivo behaviour depend strongly on molecular weight, branching, particle size, surface charge, and modifications. This review addresses how PEI/DNA complexes can be modified with targeting ligands, shielding agents…

Read the article
1999ReviewNon-viral Gene Delivery

77. Poly(ethylenimine) and its role in gene delivery

Godbey, W. T.; Wu, K. K.; Mikos, A. G

Gene therapy still lacks safe and efficient delivery vectors. PEI has emerged as a promising non-viral polycation because it condenses DNA and mediates endosomal escape, but its transfection mechanism, targeting potential, and toxicity require clearer understanding. This review summarises PEI chemistry, PEI/DNA…

Read the article
Molecular Membrane Biology1998ReviewNon-viral Gene Delivery

78. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (Review)

Hope Mj, Mui B, Ansell S, Ahkong Qf

Polymeric nucleic acid drugs—plasmid DNA, antisense oligonucleotides, and ribozymes—require protection from nucleases and efficient intracellular delivery to cytoplasm/nucleus. Viral vectors are efficient but immunogenic and safety-limited; non-viral cationic lipid systems are promising, but the mechanism of…

Read the article
1989ReviewNon-viral Gene Delivery

79. Cationic liposome-mediated transfection

Felgner Pl, Ringold Gm

Existing polynucleotide delivery methods—calcium phosphate, DEAE-dextran, electroporation, retroviral vectors—had limitations in convenience, reproducibility, efficiency, and applicability across cell types. A simple, broadly effective cationic liposome reagent was needed for DNA and RNA transfection of mammalian…

Read the article
ReviewNon-viral Gene Delivery

80. Delivery of therapeutic nucleic acids via transferrin and transferrin receptors lipoplexes and other carriers

The transferrin receptor (TfR) is overexpressed on many cancer cells and is efficiently internalised, making it a useful target for delivering small-molecule drugs and nucleic acid therapeutics while reducing non-target effects. The review summarises TfR biology, Tf-lipoplex development, and therapeutic applications…

Read the article
Articles — page 4 | Brilliant Blue Biosciences